Malcolm R. Hill's Insider Trades & SAST Disclosures

Malcolm R. Hill's most recent trade in Evoke Pharma Inc was a trade of 5,833 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 28, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Evoke Pharma Inc
Malcolm R. Hill Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2025 5,833 5,833 - - Stock Option (Right to Buy)
Evoke Pharma Inc
Malcolm R. Hill Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2024 14,625 14,625 - - Stock Option (Right to Buy)
Evoke Pharma Inc
Malcolm R. Hill Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2023 14,625 14,625 - - Stock Option (Right to Buy)
Evoke Pharma Inc
Malcolm R. Hill Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Apr 2022 57,750 57,750 - - Stock Option (Right to Buy)
Evoke Pharma Inc
Malcolm R. Hill Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 May 2020 54,000 54,000 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades